XML 61 R39.htm IDEA: XBRL DOCUMENT v3.20.4

Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disaggregation of Revenue [Line Items]
Net sales	$ 4,262	$ 3,737	$ 2,764	$ 3,588	$ 4,131	$ 3,587	$ 3,650	$ 3,516	$ 14,351	$ 14,884	$ 13,601
United States
Disaggregation of Revenue [Line Items]
Net sales									10,455	10,957	9,848
International
Disaggregation of Revenue [Line Items]
Net sales									3,896	3,927	3,753
Orthopaedics
Disaggregation of Revenue [Line Items]
Net sales									4,959	5,252	4,991
Orthopaedics | United States
Disaggregation of Revenue [Line Items]
Net sales									3,473	3,614	3,383
Orthopaedics | International
Disaggregation of Revenue [Line Items]
Net sales									1,486	1,638	1,608
Orthopaedics | Knees
Disaggregation of Revenue [Line Items]
Net sales									1,567	1,815	1,701
Orthopaedics | Knees | United States
Disaggregation of Revenue [Line Items]
Net sales									1,170	1,347	1,244
Orthopaedics | Knees | International
Disaggregation of Revenue [Line Items]
Net sales									397	469	457
Orthopaedics | Hips
Disaggregation of Revenue [Line Items]
Net sales									1,206	1,383	1,336
Orthopaedics | Hips | United States
Disaggregation of Revenue [Line Items]
Net sales									777	882	838
Orthopaedics | Hips | International
Disaggregation of Revenue [Line Items]
Net sales									429	500	498
Orthopaedics | Trauma and Extremities
Disaggregation of Revenue [Line Items]
Net sales									1,722	1,639	1,580
Orthopaedics | Trauma and Extremities | United States
Disaggregation of Revenue [Line Items]
Net sales									1,139	1,051	1,001
Orthopaedics | Trauma and Extremities | International
Disaggregation of Revenue [Line Items]
Net sales									583	588	579
Orthopaedics | Other
Disaggregation of Revenue [Line Items]
Net sales									464	415	374
Orthopaedics | Other | United States
Disaggregation of Revenue [Line Items]
Net sales									387	334	300
Orthopaedics | Other | International
Disaggregation of Revenue [Line Items]
Net sales									77	81	74
MedSurg
Disaggregation of Revenue [Line Items]
Net sales									6,400	6,492	6,045
MedSurg | United States
Disaggregation of Revenue [Line Items]
Net sales									5,036	5,189	4,743
MedSurg | International
Disaggregation of Revenue [Line Items]
Net sales									1,364	1,303	1,302
MedSurg | Instruments
Disaggregation of Revenue [Line Items]
Net sales									1,863	1,959	1,822
MedSurg | Instruments | United States
Disaggregation of Revenue [Line Items]
Net sales									1,471	1,542	1,424
MedSurg | Instruments | International
Disaggregation of Revenue [Line Items]
Net sales									392	417	398
MedSurg | Endoscopy
Disaggregation of Revenue [Line Items]
Net sales									1,763	1,983	1,846
MedSurg | Endoscopy | United States
Disaggregation of Revenue [Line Items]
Net sales									1,408	1,577	1,432
MedSurg | Endoscopy | International
Disaggregation of Revenue [Line Items]
Net sales									355	406	414
MedSurg | Medical
Disaggregation of Revenue [Line Items]
Net sales									2,524	2,264	2,118
MedSurg | Medical | United States
Disaggregation of Revenue [Line Items]
Net sales									1,910	1,787	1,630
MedSurg | Medical | International
Disaggregation of Revenue [Line Items]
Net sales									614	477	488
MedSurg | Sustainability
Disaggregation of Revenue [Line Items]
Net sales									250	286	259
MedSurg | Sustainability | United States
Disaggregation of Revenue [Line Items]
Net sales									247	283	257
MedSurg | Sustainability | International
Disaggregation of Revenue [Line Items]
Net sales									3	3	2
Neurotechnology and Spine
Disaggregation of Revenue [Line Items]
Net sales									2,992	3,140	2,565
Neurotechnology and Spine | United States
Disaggregation of Revenue [Line Items]
Net sales									1,946	2,154	1,722
Neurotechnology and Spine | International
Disaggregation of Revenue [Line Items]
Net sales									1,046	986	843
Neurotechnology and Spine | Neurotechnology
Disaggregation of Revenue [Line Items]
Net sales									1,945	1,983	1,737
Neurotechnology and Spine | Neurotechnology | United States
Disaggregation of Revenue [Line Items]
Net sales									1,182	1,281	1,115
Neurotechnology and Spine | Neurotechnology | International
Disaggregation of Revenue [Line Items]
Net sales									763	702	622
Neurotechnology and Spine | Spine
Disaggregation of Revenue [Line Items]
Net sales									1,047	1,157	828
Neurotechnology and Spine | Spine | United States
Disaggregation of Revenue [Line Items]
Net sales									764	873	607
Neurotechnology and Spine | Spine | International
Disaggregation of Revenue [Line Items]
Net sales									$ 283	$ 284	$ 221

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_KneesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_HipsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_OtherOrthopaedicsDomain
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_MedsurgMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_InstrumentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_EndoscopyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_MedicalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_SustainabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_NeurotechnologyAndSpineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_NeurotechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_SpineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: